Medtronic stock: buy or sell?
October 18th, 2019
Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide.
Should I buy Medtronic stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to define your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Medtronic stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Medtronic stock a buy?
Financial institutions and banks post stock ratings everyday.At Stocks2.com, we gathered 15 ratings published for MDT stock in the last month. The general sentiment of these ratings is bullish for MDT stock, with 11 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-28||Needham & Company LLC||n/a||Buy|
|2019-8-21||Wells Fargo & Co||n/a||Outperform|
|2019-8-21||Morgan Stanley||n/a||Equal Weight|
|2019-8-21||BMO Capital Markets||n/a||Outperform|
|2019-8-21||BMO Capital Markets||n/a||Outperform|
|2019-8-16||Royal Bank of Canada||n/a||Outperform|
|2019-8-14||Morgan Stanley||n/a||Equal Weight|
Medtronic stock analysis
Medtronic depreciated an unpleasant -0.36% and closed at $108.12.
Medtronic shares depreciated -0.36% to $108.12 on Oct 18th. On July, SMA100d and SMA200d crossed up triggering a rise of 12.19%. On Oct 9th MDT price bounced up over the SMA of 50 days demonstrating to be a significant support for this stock. On Sep 24th, MDT hit new all time highs, pushing higher previous ATH of $111.17 recorded on September 19th. New ATHs are usual entry points for many trading setups as there aren't higher resistences.
Medtronic shares grew 0.50% this week, ending at $108.12.
MDT marked an uptrend of rising tops and rising bottoms. Since its last top late September at $111.49, price slid and bounced up back from $105.00. Breaking down under $105.00 would cancel the current uptrend and it might test lower supports. Note that $111.49 might act as a resistance line. Not so far away is the last all-time high Medtronic marked late September. Since SMA20d and SMA40w crossed up late June, MDT price climbed $9.78 per share (9.95%). Since price and SMA40w lines crossed up late May, MDT climbed $21.31 (24.55%).
Medtronic stock price history
Medtronic stock historical price chart
MDT stock reached all-time highs on September/24 with a price of $111.49.
Medtronic stock price target is $115.50Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' MDT stock price predictions in the hope that they will be met as they may be wrong and not met. We have 15 price targets for Medtronic stock published in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-28||Needham & Company LLC||Reiterates||n/a||$133.00||-|
|2019-8-21||Wells Fargo & Co||Reiterates||$110.00||$120.00||9.1%|
|2019-8-21||UBS Group||Raises Target||$112.00||$122.00||8.9%|
|2019-8-21||Raymond James||Raises Target||$105.00||$118.00||12.4%|
|2019-8-21||Morgan Stanley||Raises Target||$105.00||$111.00||5.7%|
|2019-8-21||BTIG Research||Raises Target||n/a||$120.00||-|
|2019-8-21||BMO Capital Markets||Reiterates||$107.00||$118.00||10.3%|
|2019-8-21||BMO Capital Markets||Raises Target||$107.00||$118.00||10.3%|
|2019-8-16||Royal Bank of Canada||Raises Target||n/a||$110.00||-|
|2019-8-14||Morgan Stanley||Raises Target||$100.00||$105.00||5%|
Financials and fundamental analysis
Earnings date and Earnings per ShareMedtronic reported slightly fine results for 2019-Q1 on February. Medtronic gained Earnings per Share (EPS) by 4.00%, beating experts estimates of $1.24. Medtronic posted $1.29.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Medtronic annual sales stayed constant a neutral 0.01% to $29,953.00 M USD from $29,950.00 marked in 2018. In the same way, its profit margin (compared to sales) remained stable to 10.36%, that is $3,104.00 million. To have an up to date view of the financial situation of Medtronic, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Medtronic TTM sales up to January 2019 were $30,555.00 and earnings were $4,919.00 M dollars. When comparing this TTM figures with the last reported annuality, we can esteem Medtronic business evolution since April 2018: Annual turnover up to January, compared to lastest yearly report, gained a tiny 2.01%. Similarly, profit margin (net income/revenues) soared at 10.36%.
|2014||$17,010 M||-||$3,070 M18.0%||-|
|2014||$17,010 M||0.00%||$3,070 M18.0%||0.00%|
|2015||$20,260 M||19.11%||$2,680 M13.2%||-12.70%|
|2015||$20,261 M||0.00%||$2,675 M13.2%||-0.19%|
|2016||$28,830 M||42.29%||$3,540 M12.3%||32.34%|
|2016||$28,833 M||0.01%||$3,538 M12.3%||-0.06%|
|2017||$29,710 M||3.04%||$4,030 M13.6%||13.91%|
|2017||$29,710 M||0.00%||$4,028 M13.6%||-0.05%|
|2018||$29,950 M||0.81%||$3,100 M10.4%||-23.04%|
|2018||$29,953 M||0.01%||$3,104 M10.4%||0.13%|
|TTM||$30,555 M||2.01%||$4,919 M16.1%||58.47%|
Quarterly financial resultsMedtronic reported $7,546.00 million in sales for 2019-Q1, a 0.87% up compared to previous quarter. Reported quarter income marked $1,269.00 million with a profit margin of 16.82%. Profit margin inched a 1.91% compared to previous quarter when profit margin was 14.90%. When comparing revenues to same quarter last year, Medtronic sales marked a slightly good growth and raised a 2.40%. Looking back to recent quarterly results, Medtronic posted 2 negative quarters in a row.
|2017-Q2||$7,920 M||-||$1,160 M14.6%||-|
|2017-Q3||$7,390 M||-6.69%||$1,020 M13.8%||-12.07%|
|2017-Q4||$7,050 M||-4.60%||$2,017 M28.6%||97.75%|
|2018-Q1||$7,369 M||4.52%||$-1,389 M-18.8%||-168.86%|
|2018-Q2||$8,144 M||10.52%||$1,460 M17.9%||-205.11%|
|2018-Q3||$7,384 M||-9.33%||$1,075 M14.6%||-26.37%|
|2018-Q4||$7,481 M||1.31%||$1,115 M14.9%||3.72%|
|2019-Q1||$7,546 M||0.87%||$1,269 M16.8%||13.81%|
Medtronic ownershipWhen you are planning to invest in shares of a company, it's worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medtronic, 0.06% of all outstanding shares are owned by its staff.
Bearish positions for MDT stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related companies:
|Market cap||$144.9 B||$146.5 B||$44.9 B||$53.5 B||$2.8 B|
|Total shares||1,340.0 M||1,770.0 M||510.6 M||1,390.0 M||28.3 M|
|Float shares||1,340.0 M||1,750.0 M||509.6 M||1,390.0 M||27.6 M|
|- Institutional holdings (%)||84.2%||76.5%||88.2%||93.4%||97.5%|
|- Insider holdings (%)||0.1%||0.7%||0.1%||0.2%||1.8%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, October 18th, 2019|
|Day range||$107.96 - $108.91|
|Average true range||$1.60|
|50d mov avg||$106.92|
|100d mov avg||$102.60|
|200d mov avg||$95.23|
Medtronic performanceTo measure stock performance is always good to benchmark with competitors or related stocks. We selected , Baxter International, Boston Scientific, CONMED, Edwards Lifesciences, Integra LifeSciences, , Owens & Minor, Stryker and Zimmer Biomet as the bechmarking frame for Medtronic stock.
|OMIOwens & Minor||170.45%||111.87%||-51.72%|
Medtronic competitorsWe picked a few stocks to conform a list of Medtronic competitors to check if you are interested in investing in MDT:
- Baxter International (BAX)
- Boston Scientific (BSX)
- CONMED (CNMD)
- Edwards Lifesciences (EW)
- Integra LifeSciences (IART)
- Owens & Minor (OMI)
- Stryker (SYK)
- Zimmer Biomet (ZBH)
Latest Medtronic stock news
- InvestorPlace3 Big Stock Charts for Monday: Medtronic, Paychex and AbbVieJune 24, 2019
- InvestorPlace3 Big Stock Charts for Friday: Medtronic, LKQ and Lamb WestonMarch 15, 2019
- InvestorPlaceMedtronic Earnings: MDT Reports Q3 Earnings BeatFebruary 19, 2019
- InvestorPlace3 Big Stock Charts for Tuesday: Microsoft, Medtronic and Intercontinental ExchangeJanuary 8, 2019
- InvestorPlace3 Big Stock Charts for Thursday: Medtronic, Facebook and eBayJanuary 3, 2019